hrp0098p3-66 | Diabetes and Insulin | ESPE2024

An Audit Evaluating Omnipod® 5 usage in Patients Under the Care of the Paediatric Diabetes Team at Wythenshawe Hospital

O'Brien Rachael , Butterfield Lucy

56 patients under the care of the paediatric diabetes team at Wythenshawe Hospital were identified as current Omnipod® 5 insulin pump users for Type 1 Diabetes Mellitus management in April 2024. Time in range (TIR) i.e. the time spent with blood glucose in the normal range, total daily dose (TDD) of insulin, BMI Z-score along with total daily carbohydrate intake (CHO) and insulin boluses (TDB) during the first six months of pump therapy were compared against those of their...